The FDA Is Severely Restricting the Sale of Flavored E-Cigarettes. Here ’s What to Know
The Food and Drug Administration (FDA) on Thursday followed through on a rumored plan to significantly restrict the sale of flavored e-cigarettes in an effort to keep young users away from tobacco products. “The bottom line is this: I will not allow a generation of children to become addicted to nicotine through e-cigarettes,” said FDA Commissioner Dr. Scott Gottlieb in a statement. “We won’t let this pool of kids, a pool of future potential smokers, of future disease and death, to continue to build. We’ll take whatever action is necessary to stop these trends from continuing.” That act...
Source: TIME: Health - November 15, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime public health Source Type: news

NuVasive Launches First-Of-Its-Kind Brigade(R) Lateral Implant And Instrumentation Optimized For Lateral Anterior Lumbar Interbody Fusion Spine Surgery
SAN DIEGO, Nov. 15, 2018 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today annou... Devices, Orthopaedic, Neurosurgery, Product Launch NuVasive, Brigade Lateral, anterior lumbar, interbody fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2018 Category: Pharmaceuticals Source Type: news

FDA restrictions on e-cigarettes important step to protect the health of youth
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center applauds new actions announced today by the US Food and Drug Administration (FDA) to limit the sale of most flavored electronic cigarettes (e-cigarettes) to age-restricted locations and require age-verification for online sales to lower the use of these products in children. In addition, the FDA plans to restrict the marketing of these products toward youth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2018 Category: Cancer & Oncology Source Type: news

Merit Medical closes $200m Cianna Medical buy
Merit Medical (NSDQ:MMSI) said yesterday that it closed its $200 million acquisition of Cianna Medical, making the company a wholly-owned subsidiary. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won 510(k) clearance from the FDA in December 2014. The deal included an up-front cash payment of $135 million, plus $15 million in earn-outs pegged to supply chain and scalability goals and another $50 million in ...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Mergers & Acquisitions Women's Health Cianna Medical Merit Medical Systems Inc. Source Type: news

Nektar Appoints Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs
SAN FRANCISCO, Nov. 14, 2018 -- (Healthcare Sales & Marketing Network) -- Nektar Therapeutics (Nasdaq: NKTR) today announced the appointment of Wei Lin, M.D., as Senior Vice President of Clinical Development and Head of Nektar's Oncology Programs. In this... Biopharmaceuticals, Oncology, Personnel Nektar Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

Vapotherm prices $56m IPO
Vapotherm yesterday priced an initial public offering, aiming to raise $56 million for its respiratory device. Exeter, N.H.-based Vapotherm developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said. Vapotherm said it plans to issue 4 million shares at $14 apiece, hitting the low end of its prior range. The offering also includes a 30-day underwrit...
Source: Mass Device - November 14, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Initial Public Offering (IPO) Respiratory Wall Street Beat Vapotherm Source Type: news

Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
AACHEN, Germany and MORRISTOWN, New Jersey, November 14, 2018 -- (Healthcare Sales & Marketing Network) - Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint ... Biopharmaceuticals, Mergers & Acquisitions Grünenthal Group, Averitas Pharma, Qutenza, capsaicin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 14, 2018 Category: Pharmaceuticals Source Type: news

‘Rapid release’ Tylenol gelcaps are slower to dissolve than cheaper tablets, study finds
The study shows one way marketing messages on over-the-counter medicines could be misleading consumers. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 14, 2018 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news

Merit Puts a Bow On Cianna Medical Acquisition
Merit Medical Systems has completed the acquisition of Aliso Viejo, CA-based, Cianna Medical. The South Jordan, UT-based company put an upfront payment of $135 million with potential earn-out payments of an additional $15 million for achievement of supply chain and scalability metrics, and up to an additional $50 million for achievement of sales milestones. Merit said that Cianna specializes in wire-free breast localization and has been focused on breast conservation for 11 years. Its research, development and commercialization teams developed a non-radioactive, wire-free breast localization system and technology that uses...
Source: MDDI - November 14, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Juul Suspends Selling Most E-Cigarette Flavors in Stores
Juul will restrict sales of nearly all its flavored pods to the internet, and stop most social media promotion to combat youth vaping, bowing to government and public pressure. (Source: NYT Health)
Source: NYT Health - November 14, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN and JAN HOFFMAN Tags: Juul Labs Inc E-Cigarettes Smoking and Tobacco Teenagers and Adolescence Social Media Advertising and Marketing Food and Drug Administration Regulation and Deregulation of Industry Source Type: news

Juul Will Suspend Selling Most E-Cigarette Flavors in Stores and Halt Social Media Promotions
Juul will restrict sales of nearly all its flavored pods to the internet, and stop most social media promotion to combat youth vaping, bowing to government and public pressure. (Source: NYT Health)
Source: NYT Health - November 13, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN and JAN HOFFMAN Tags: E-Cigarettes Smoking and Tobacco Teenagers and Adolescence Social Media Advertising and Marketing Food and Drug Administration Juul Labs Inc vaping Source Type: news

To Fight Teen Vaping, JUUL Will Stop Retail Sales Of Flavors
By Susan Scutti, CNN (CNN) — The CEO of e-cigarette maker Juul announced plans Tuesday to eliminate some of its social media accounts and halt most retail sales of flavor products as part of a plan to restrict access to minors. The plan came in response to the US Food and Drug Administration’s September announcement that it would investigate major e-cigarette makers and review their sales and marketing practices. “Our intent was never to have youth use JUUL,” Kevin Burns wrote in the Tuesday statement that outlined an action plan divided into four key areas: flavors, retail stores, social ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 13, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News CNN e-cigarettes JUUL vaping Source Type: news

Juul Will Stop Selling Most E-Cigarette Flavors in Stores and Halt Social Media Promotions
Juul will restrict sales of nearly all its flavored pods to online only, and stop most social media promotion to combat youth vaping, bowing to government and public pressure. (Source: NYT Health)
Source: NYT Health - November 13, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN and JAN HOFFMAN Tags: E-Cigarettes Smoking and Tobacco Teenagers and Adolescence Social Media Advertising and Marketing Food and Drug Administration Juul Labs Inc vaping Source Type: news

Juul to eliminate social media accounts, stop retail sales of flavors
The CEO of e-cigarette maker Juul announced plans Tuesday to eliminate some of its social media accounts and halt most retail sales of flavor products as part of a plan to restrict access to minors. The plan came in response to the US Food and Drug Administration's September announcement that it would investigate major e-cigarette makers and review their sales and marketing practices. (Source: CNN.com - Health)
Source: CNN.com - Health - November 13, 2018 Category: Consumer Health News Source Type: news

STERIBITE(R) Announces FDA Clearance of the Steribite Disposable Kerrison Rongeur
CLEVELAND, Nov. 13, 2018 -- (Healthcare Sales & Marketing Network) -- STERIBITE, LLC, a medical device company focused on developing unique, disposable surgical instruments, today announced it has received 510(k) clearance from the FDA to market its first... Devices, Orthopaedic, Neurosurgery, FDA STERIBITE, Kerrison Rongeur, Rongeur (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

FDA warns StemGenex Biologic Laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk
(Source: Food and Drug Administration)
Source: Food and Drug Administration - November 13, 2018 Category: American Health Source Type: news

Executive Committee Minutes, September 11, 2018
Participants: Peter Elias, John Grohol, Janice McCallum, Danny Sands, Joe Ternullo, Sue Woods Minutes from August 14 meeting (Janice) approved Learning Exchange (Sarah) September Learning Exchange was held earlier on the day of this Executive Committee meeting. Webinar was excellent, but attendance was low. Timing of the promotions in late August likely played a role. Also, there were some negative comments about the registration process, which required a company name. Patients who don’t work for a company may find this off-putting. Also, when clicking the Webex link to attend webinar, it required registering again. ...
Source: Society for Participatory Medicine - November 13, 2018 Category: General Medicine Authors: Janice McCallum Tags: Executive Minutes Executive Committee Meetings Executive Committee Minutes Source Type: news

NeuroStar(R) Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment
TMS therapy provider will be offering NeuroStar Advanced Therapy at six new locations MALVERN, Pa., Nov. 13, 2018 -- (Healthcare Sales & Marketing Network) -- NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation ... Devices, Neurology, Distribution NeuroStar Advanced Therapy, GRW Health, transcranial magnetic stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Developing Targeted Therapies With Potential Applicability Across Many Cancer Types GUILDFORD, England, November 13, 2018 -- (Healthcare Sales & Marketing Network) -- HOX Therapeutics, the private biotechnology company developing first-in-class, highly... Biopharmaceuticals, Oncology, Personnel HOX Therapeutics, HOX genes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
STOCKHOLM, Nov. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into agreements to acquire the perpetual rights to Synagis® (palivizumab) in the US from AstraZeneca and to partici... Biopharmaceuticals, Acquisitions Swedish Orphan Biovitrum, Sobi , AstraZeneca, Synagis, palivizumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 13, 2018 Category: Pharmaceuticals Source Type: news

Cantel to Acquire Omnia S.p.A.
Acquisition of dental surgical consumables company will accelerate Company's dental infection prevention presence in Europe LITTLE FALLS, N.J., Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Cantel Medical Corp. (NYSE: CMD), announced today... Devices, Dental, Surgery, Mergers & Acquisitions CANTEL MEDICAL, Omnia, medical device reprocessing, reprocessing (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

Collidion Announces Settlement of Sonoma Litigation
PETALUMA, Calif., Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Sonoma Pharmaceuticals, Inc. ("Sonoma") and Collidion Inc. ("Collidion") have today announced agreement to settle Sonoma's claims of trade secret misappropria... Biopharmaceuticals, Litigation Collidion, Sonoma Pharmaceuticals, hypochlorous acid (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

Nestle ups stake in food allergy drug developer
Nestle ’s health science arm will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment before the end of the year. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 12, 2018 Category: Pharmaceuticals Source Type: news

Nestle raises stake in food allergy drug developer Aimmune
The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment by the end of the year. (Source: Reuters: Health)
Source: Reuters: Health - November 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Lannett Enters Into Agreement With Amneal Pharmaceuticals For Levothyroxine
Lannett Locks in $50 Million of Gross Profit for 16-Week Period PHILADELPHIA, Nov. 12, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Amneal Pharmaceuticals... Biopharmaceuticals, Generics, Distribution Lannett Company, Amneal Pharmaceuticals, Levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
Collaboration Combines CollPlant’s Proprietary rhCollagen-based BioInk Technology and United Therapeutics’ Regenerative Medicine and Organ Manufacturing Capabilities NESS ZIONA, Israel, November 12, 2018 -- (Healthcare Sales & Marketing Network) -- Col... Devices, Regenerative Medicine, Licensing CollPlant, United Therapeutics, Lung Biotechnology PBC, 3D bioprinting (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2018 Category: Pharmaceuticals Source Type: news

Dear vegans: your "vegan" cheese is made with DAIRY protein – Watch at Brighteon.com
(Natural News) Marketing is one of the keys to maintaining consumer demand. But sometimes marketers go a wee-bit overboard, stretching the truth about whatever good and service they’re trying to sell in order to maximize profits. In a recent video update, Mike Adams, the Health Ranger, discussed this very thing as it pertains to so-called... (Source: NaturalNews.com)
Source: NaturalNews.com - November 11, 2018 Category: Consumer Health News Source Type: news

Google picks up Geisinger's CEO, Greenway Health names new president and other digital health hires
Also: Justin Nelson to join AristaMD as VP of sales; Barry Gutwillig named VP of sales and marketing for Patient Keeper.   (Source: mobihealthnews)
Source: mobihealthnews - November 9, 2018 Category: Information Technology Source Type: news

FDA authorizes emergency use of first Ebola fingerstick test with portable reader
SILVER SPRING, Md., Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Today, the U.S. Food and Drug Administration announced that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus (Z... Diagnostics, FDA Chembio Diagnostic Systems, Ebola virus, DPP Ebola Antigen System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

Fighting Teen Vaping, FDA Plans Crackdown On Flavored E-Cigarettes
By Jamie Gumbrecht, CNN (CNN) — Taking on epidemic levels of teen e-cigarette use, the US Food and Drug Administration is expected to announce new restrictions on the sale of e-cigarette products an agency official confirmed Thursday. FDA Commissioner Scott Gottlieb is expected to announce a ban on the sale of most flavored e-cigarettes in convenience stores and gas stations as early as next week. The agency will impose age-verification requirements for online sales. Flavored e-cigarette products would be available in vape and tobacco shops. Gottlieb is also expected to propose a ban on menthol in regular cigare...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 9, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN e-cigarettes Source Type: news

ReWalk Announces Placement of 500th Exoskeleton System
Robotic exoskeleton manufacturer has provided life changing medical devices for persons with spinal cord injury in 26 countries MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- ReWalk Robotics Ltd. ... Devices ReWalk Robotics, robotic exoskeleton, exoskeleton, spinal cord injury (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset
New MappingHepC.com website provides HCV community an easily accessible source of chronic HCV epidemiology data NORTH CHICAGO, Ill., Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutica... Biopharmaceuticals, Diagnostics AbbVie, Hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine... Biopharmaceuticals, Regulatory Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

F.D.A. Plans to Ban Most Flavored E-Cigarette Sales in Stores
After warning Juul and other e-cigarette makers to keep their flavored products away from minors, the F.D.A. wants to curb sales altogether. (Source: NYT Health)
Source: NYT Health - November 9, 2018 Category: Consumer Health News Authors: SHEILA KAPLAN Tags: Smoking and Tobacco E-Cigarettes Advertising and Marketing Food and Drug Administration Juul Labs Inc Source Type: news

TransEnterix posts Street-beating Q3
TransEnterix (NYSE:TRXC) today posted third quarter earnings that beat expectations on Wall Street. The Research Triangle Park, N.C.-based company posted losses of $20.2 million, or 10¢ per share, on sales of $5.4 million for the three months ended September 30, seeing losses shrink 47.5% while sales grew nearly 3000% compared with the same period during the previous year Adjusted to exclude one-time items, losses per share were 6¢, just ahead of the 7¢ loss-per-share consensus on Wall Street where analysts expected to see sales of $5.3 million, which TransEnterix topped. “We are proud of the prog...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured MassDevice Earnings Roundup Wall Street Beat TransEnterix Source Type: news

Strategist of the Year: Bob Hinckley of CDPHP
CDPHP ’s marketing strategy includes shared bikes and free fitness centers. That’s just part of the job for Bob Hinckley, who’s also watching how the political debate over health care will play out. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 8, 2018 Category: American Health Authors: Liz Young Source Type: news

CareerFusion to the Next Level with CareerFusion 2
Call for Speaker Abstract Submissions is Now Open,Re-Launch Special Tuition and Sponsor Fees Are in EffectDaytona Beach, FL – November 01, 2018 –CareerFusion, one of dentistry ’s first professional development workshop platforms is being updated and relaunched as CareerFusion 2. CareerFusion 2 is a dedicated group of multi-generational, inter-disciplinary thought-leaders, coaches and mentors who help their clinical colleagues achieve professional development, personal growth and optimal life balance during each phase of their careers. According to company founder Beth Thompson, RDH, “...
Source: Dental Technology Blog - November 8, 2018 Category: Dentistry Source Type: news

OncoSec Appoints Robert Ward to its Board of Directors
Seasoned Biopharmaceutical Industry Leader Brings Extensive Experience in Drug Development and Commercialization SAN DIEGO and PENNINGTON, N.J., Nov. 8, 2018 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: O... Biopharmaceuticals, Oncology, Personnel OncoSec Medical, intratumoral cancer immunotherapies, TAVO (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2018 Category: Pharmaceuticals Source Type: news

Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HOLLISTON, Mass., Nov. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today an... Devices, Regenerative Medicine, Personnel Biostage, bioengineered organ implant, Cellframe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2018 Category: Pharmaceuticals Source Type: news

Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
Sharp to Bring Additional Financial Expertise to Sutro's Board SAN FRANCISCO, Nov. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sutro Biopharma, Inc. (NASDAQ: STRO), today announced that Shalini Sharp, Chief Financial Officer and Executive Vice... Biopharmaceuticals, Oncology, Personnel Sutro Biopharma, XpressCF+ (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 8, 2018 Category: Pharmaceuticals Source Type: news

All this 500,000-square-foot Berkeley biotech project needs is a developer
An eight-acre Berkeley site near Aquatic Park has hit the market, promoted as a potential 475,000-square-foot office project or life science campus. Commercial brokerage firm JLL (NYSE: JLL) is marketing the site at the foot of Addison Street, east of Interstate 80, to potential developers that could take advantage of a biotech building boom in which hundreds of thousands of square feet are being taken quickly, often months before structures a re completed. While the East Bay's premier life sciences… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 7, 2018 Category: Health Management Authors: Ron Leuty Source Type: news

All this 500,000-square-foot Berkeley biotech project needs is a developer
An eight-acre Berkeley site near Aquatic Park has hit the market, promoted as a potential 475,000-square-foot office project or life science campus. Commercial brokerage firm JLL (NYSE: JLL) is marketing the site at the foot of Addison Street, east of Interstate 80, to potential developers that could take advantage of a biotech building boom in which hundreds of thousands of square feet are being taken quickly, often months before structures a re completed. While the East Bay's premier life sciences… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 7, 2018 Category: Biotechnology Authors: Ron Leuty Source Type: news

Myomo posts Q3 earnings, touts Medicare win
Shares in Myomo fell slightly today after the medical device maker posted Q3 earnings that narrowly missed Wall Street expectations, and announced reimbursement wins with the Centers for Medicare & Medicaid Services. The Cambridge, Mass.-based company posted losses of $7.6 million, or 21¢ per share, on sales of $610,000 for the three months ended September 30, seeing losses shrink 25.2% while sales grew 24.5% compared with the same period during the previous year. Losses-per-share were just behind the 19¢ consensus on Wall Street, where analysts expected to see sales of approximately $767,000, which...
Source: Mass Device - November 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Myomo Inc Source Type: news

8 Things You Should Know about the EU MDRs
A recent survey by the Regulatory Affairs Professionals Society (RAPS) and KPMG revealed some shocking statistics. According to “The Race to EU MDR Compliance,”a solid majority (78%) of medical device companies responding to the survey do not have a sufficient understanding of EU MDR. And even more shocking: more than half of respondents (58%) have no strategy in place to remediate gaps in their clinical data or processes for collecting data, despite the new regulatory expectations for such data. Education is clearly still needed to help companies prepare for May 2020, when the EU MDRs b...
Source: MDDI - November 7, 2018 Category: Medical Devices Authors: Daphne Allen Tags: Regulatory and Compliance Source Type: news

Ms. Ting Li Appointed to Biostage Board of Directors
HOLLISTON, Mass., Nov. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus, and trachea, today a... Regenerative Medicine, Personnel Biostage, bioengineered organ implant, Cellframe (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 7, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Ortho Clinical Diagnostics VITROS(R) Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator for use on the VITROS(R) 5600 Integrated System
Expanded use on the VITROS® 5600 Integrated System will help Labs Maximize Workflow Efficiencies RARITAN, N.J., Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, announced... Diagnostics, HIV/AIDS, FDA Ortho Clinical Diagnostics, VITROS, HIV Combo Reagent Pack (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

PatientPop raises $25M for digital practice marketing service
The new funding, led by Leerink Transformation Partners, brings PatientPop's total backing to $75 million.   (Source: mobihealthnews)
Source: mobihealthnews - November 6, 2018 Category: Information Technology Source Type: news

Cumberland Pharmaceuticals To Acquire VIBATIV(R)
FDA approved injectable anti-infective with life-saving potential NASHVILLE, Tenn., Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a definitive agreement... Biopharmaceuticals, Acquisitions Cumberland Pharmaceuticals, Theravance Biopharma, VIBATIV, telavancin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan(TM) Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia
These nondilutive funds support development, testing and IND submission of the Company's pediatric esophageal implant candidate HOLLISTON, Mass., Nov. 6­­­, 2018 -- (Healthcare Sales & Marketing Network) -- Biostage, Inc. (OTCQB: BSTG), a b... Regenerative Medicine Biostage, Cellspan, Esophageal Implant, Cellframe, esophageal atresia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news

Lannett Announces Expanded Agreement With Strategic Alliance Partner, HEC Pharm Group, To Distribute Two FDA-Approved Products
Company Has Commenced Launch of Clarithromycin and Expects to Begin Marketing Entacapone In Early Calendar Year 2019 PHILADELPHIA, Nov. 6, 2018 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has e... Biopharmaceuticals, Licensing, Distribution Lannett Company, Sunshine Lake, HEC Pharm Group, clarithromycin, entacapone (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 6, 2018 Category: Pharmaceuticals Source Type: news